Sorafenib-induced hepatic encephalopathy

MeSH terms

• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / adverse effects*
• Antineoplastic Agents / therapeutic use
• Benzenesulfonates / administration & dosage
• Benzenesulfonates / adverse effects*
• Benzenesulfonates / therapeutic use
• Carcinoma, Hepatocellular / drug therapy
• Dose-Response Relationship, Drug
• Hepatic Encephalopathy / chemically induced*
• Humans
• Liver Neoplasms / drug therapy
• Middle Aged
• Niacinamide / analogs & derivatives
• Phenylurea Compounds
• Pyridines / administration & dosage
• Pyridines / adverse effects*
• Pyridines / therapeutic use
• Sorafenib
• Time Factors